-
The Economics of Antibiotic Resistance
The business model for developing new antibiotics is broken, researchers say. The question is, can we make a new one that works?
- Categories
- Health Care
- Tags
- public health
-
‘There’s no point giving free cancer drugs to Africa’
Giving out free cancer drugs would not help the poorest parts of Africa, the head of pharmaceutical giant AstraZeneca has told the BBC.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- public health
-
With Another Pandemic Looming, Let’s Change Perspective
We cannot prevent the emergence of new viruses, according to Dr. Melvin Sanicas, a Global Health Fellow and program officer at the Bill & Melinda Gates Foundation, but we can take measures to prevent small epidemics from becoming big ones, including investing in infrastructures for preparedness.
- Categories
- Health Care
-
Hepatitis C drugs remain unaffordable in many countries, says WHO study
In the latest effort to quantify the burden of expensive medicines, a new study found that the cost of two widely used hepatitis C treatments remains out of reach for people in many poor countries and poses a “financial and ethical dilemma” for payers and doctors. The study found that if a patient paid for treatment out of pocket, the cost of a full course of Sovaldi alone would equal one year or more of average earnings for people in 12 countries.
- Categories
- Health Care
- Tags
- public health
-
‘Clubfoot Can Be Solved on a Global Scale’
miraclefeet believes clubfoot can be solved on a global scale and envisions a world where every child can receive treatment. The five-year-old organization partners with local health care providers in public hospitals to support the Ponseti treatment and to ultimately create sustainable clubfoot programs in low-resource countries.
- Categories
- Health Care
-
India’s New Patent Policy Spurs Debate Over Implications for Pharma
Amid an ongoing rift with the US government, India last week issued a new policy about intellectual property, but opinions are divided over whether the move will appease the pharmaceutical industry, which has been pushing the Indian government to strengthen patent protection.
- Categories
- Health Care
- Region
- South Asia
- Tags
- public health
-
Viewpoint: Secret Vote on WHO Bodes Ill for Future of Global Health
With the future of global health more uncertain than it has been in more than a decade, the first hats have been tossed into the election ring for top leadership at the World Health Organization. It is a dire time for WHO, which has seen its financial and political support erode steadily for the last decade, its credibility suffering mightily over its slow and sloppy response to the 2014 Ebola outbreak.
- Categories
- Health Care
- Tags
- public health
-
Public-Private Deal Rejuvenates Healthcare in Rajasthan – At a Cost
In the women’s ward, two newborns are sleeping beside their mothers, one of whom is happy because hers is a boy. The other is unhappy because her child is a girl, and her sixth daughter.
- Categories
- Health Care
- Region
- South Asia
The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.